
PAAS vs GMAB
$PAAS vs $GMAB head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
PAAS vs GMAB: the quick read
- ·GMAB is the larger company by market cap ($21.67B vs $20.73B).
- ·PAAS has been more active on our scanner (153 vs 48 alerts in 30 days).
- ·PAAS has the smaller float (414.6M vs 613.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Gold and Silver Ores vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·PAAS draws far more of our scanner's attention, 153 unusual-volume alerts in 30 days against 48, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 5% of each other on market cap, which makes the rest of this table the interesting part.
- ·PAAS pays a dividend and GMAB does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing PAAS and GMAB on TheDesperateTrader.
- Is PAAS or GMAB the better stock?
- "Better" depends on your goal, and these two are not alike. GMAB is the larger company by market cap ($21.67B vs $20.73B). PAAS has been more active on our scanner (153 vs 48 alerts in 30 days). PAAS has the smaller float (414.6M vs 613.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between PAAS and GMAB?
- The differences that matter: they are not in the same business - PAAS is gold and silver ores and GMAB is pharmaceutical preparations; they are similar in size ($20.73B vs $21.67B); they trade at very different share prices ($50.11 vs $34.73); PAAS sits at 46% of its 52-week range against 94% for GMAB; only PAAS pays a dividend; our scanner flagged PAAS 153 times in the last 30 days against 48 for GMAB. Everything above is measured from the latest completed session and SEC filings.
- Which of PAAS and GMAB is more active right now?
- Right now PAAS is at about 0.9x its normal volume and GMAB is at about 1.1x, so GMAB is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading PAAS or GMAB? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore PAAS and GMAB comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.